Topics

High-grade gliomas | Treatment | Clinical trials | Interleukins

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Interleukins

Campian JL, Grossman SA, Kask AS, Kosydar S, Strowd R, Piotrowski A, Tang J, Chheda MG, DiPersio JF, Schullery D, D'Amico L, Desideri S, Danda N, Ferrando-Martinez S, Lee BH, Fling SP, Ye X.
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.
Neurooncol Adv. 2025 Jun 7;7(1):vdaf117. doi: 10.1093/noajnl/vdaf117. PMID: 40703805. Interventional study. ˍ AI Overview